Cargando…
Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG)
BACKGROUND: Discrepant data have been published on the incidence and prognostic significance of ESR1 gene amplification in early breast cancer. PATIENTS AND METHODS: Formalin-fixed paraffin-embedded tumor blocks were collected from women with early breast cancer participating in two HeCOG adjuvant t...
Autores principales: | Pentheroudakis, George, Kotoula, Vassiliki, Eleftheraki, Anastasia G., Tsolaki, Eleftheria, Wirtz, Ralph M., Kalogeras, Konstantine T., Batistatou, Anna, Bobos, Mattheos, Dimopoulos, Meletios A., Timotheadou, Eleni, Gogas, Helen, Christodoulou, Christos, Papadopoulou, Kyriaki, Efstratiou, Ioannis, Scopa, Chrisoula D., Papaspyrou, Irene, Vlachodimitropoulos, Dimitrios, Linardou, Helena, Samantas, Epaminontas, Pectasides, Dimitrios, Pavlidis, Nicholas, Fountzilas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726626/ https://www.ncbi.nlm.nih.gov/pubmed/23923010 http://dx.doi.org/10.1371/journal.pone.0070634 |
Ejemplares similares
-
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
por: Fountzilas, George, et al.
Publicado: (2013) -
Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study
por: Papaxoinis, George, et al.
Publicado: (2015) -
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study
por: Koutras, Angelos, et al.
Publicado: (2015) -
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study
por: Koutras, Angelos, et al.
Publicado: (2018) -
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy
por: Fountzilas, George, et al.
Publicado: (2012)